‘I don’t know of a time that was worse’: What to know about cancer drug shortages

By Mariah Taylor on June 15, 2023 for Becker’s Hospital Review

A survey found 93 percent and 70 percent of cancer centers are struggling with shortages of carboplatin and cisplatin, respectively, and while the FDA is trying to increase supply, hospitals are struggling to help patients. Here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org